Published in Prog Cardiovasc Dis on June 15, 1994
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med (2009) 0.80
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Fatal pulmonary embolism in hospitalized patients: a large autopsy-based matched case-control study. Clinics (Sao Paulo) (2013) 0.78
Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities. Thromb Res (2015) 0.75
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Is it time to pull the pulmonary artery catheter? JAMA (1996) 5.69
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
Is integrative medicine the medicine of the future? A debate between Arnold S. Relman, MD, and Andrew Weil, MD. Arch Intern Med (1999) 3.33
A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation (1993) 3.31
Health care in America: the good, the bad, and the ugly. Arch Intern Med (2000) 2.92
Paradoxical embolism. Diagnosis during life. Am J Med (1972) 2.85
Natural history of pulmonary embolism. Prog Cardiovasc Dis (1975) 2.83
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1992) 2.76
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest (2001) 2.72
Cholesterol and violent behavior. Arch Intern Med (1994) 2.64
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med (1980) 2.33
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1998) 2.17
Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med (1991) 1.99
Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J (1988) 1.89
Sounding Board. CPR training for physicians. N Engl J Med (1980) 1.74
A bold proposal to achieve near-universal health care coverage in the United States. Arch Intern Med (2000) 1.71
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1998) 1.67
Basic life support. J Med Educ (1978) 1.50
An apple a day or an aspirin a day? Arch Intern Med (1991) 1.48
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J (1990) 1.48
Late prognosis of acute pulmonary embolism. N Engl J Med (1973) 1.47
Early reduction of pulmonary vascular resistance after mitral-valve replacement. N Engl J Med (1967) 1.47
The electrocardiogram in acute pulmonary embolism. Prog Cardiovasc Dis (1975) 1.46
The moribund autopsy. DNR or CPR? Arch Intern Med (1997) 1.42
Cardiovascular disease. JAMA (1992) 1.39
US physician manpower needs. Generalists and specialists: achieving the balance. Arch Intern Med (1996) 1.38
Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol (1984) 1.33
The hemodynamic and respiratory effects of diazepam (Valium). Anesthesiology (1969) 1.29
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest (2001) 1.28
Resolution rate of acute pulmonary embolism in man. N Engl J Med (1969) 1.27
Diagnostic senstivity of laboratory findings in acute pulmonary embolism. Ann Intern Med (1971) 1.26
Dissection of the thoracic aorta. Medical or surgical therapy? Am J Cardiol (1974) 1.26
The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J (1989) 1.25
Syncope in patients with pulmonary embolism. JAMA (1977) 1.25
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1995) 1.24
Pulmonary angiography in acute pulmonary embolism: indications, techniques, and results in 367 patients. Am Heart J (1971) 1.23
Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med (1987) 1.20
Layperson CPR--are we training the right people? Ann Emerg Med (1984) 1.15
A noninvasive technique for the determination of velocity of circumferential fiber shortening in man. Circ Res (1971) 1.15
Health maintenance activities of physicians and nonphysicians. Arch Intern Med (1988) 1.13
A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol (1993) 1.13
A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest (1987) 1.11
Does pulmonary artery catheterization benefit patients with acute myocardial infarction? Chest (1990) 1.10
Mortality in patients treated for pulmonary embolism. JAMA (1976) 1.09
Changes in the inotropic state of the left ventricle during isometric exercise. Br Heart J (1973) 1.05
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1995) 1.05
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1992) 1.04
The angiographic diagnosis of acute pulmonary embolism: evaluation of criteria. Am Heart J (1967) 1.04
Pulmonary angiography in experimental pulmonary embolism. Am Heart J (1966) 1.04
Time of onset of symptoms of acute myocardial infarction. Am J Cardiol (1990) 1.02
Bedside hemodynamic monitoring. N Engl J Med (1979) 1.02
Preliminary experience with synchronized coronary sinus retroperfusion in humans. Circulation (1986) 1.01
Coronary spasm, coronary thrombosis, and myocardial infarction: a hypothesis concerning the pathophysiology of acute myocardial infarction. Am Heart J (1982) 0.99
The pulmonary artery catheter-friend, foe, or accomplice? JAMA (2001) 0.98
Effects of physical training on hemodynamics and pulmonary function at rest and during exercise in patients with chronic obstructive pulmonary disease. Chest (1974) 0.98
Pulmonary embolism. JAMA (1969) 0.96
Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest (1998) 0.96
The natural history of pulmonary embolism. Clin Chest Med (1984) 0.95
When can treatment be withheld in patients with suspected pulmonary embolism? Arch Intern Med (1993) 0.95
Physicians' attitudes and practices toward CPR training in family members of patients with coronary heart disease. Am J Public Health (1985) 0.94
Paradoxical embolism: its pathophysiology and clinical recognition. Ann Surg (1970) 0.94
Tocainide for refractory ventricular arrhythmias of myocardial infarction. Am Heart J (1980) 0.93
Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction. Arch Intern Med (1989) 0.93
The relationship of patient characteristics to physician delivery of advice to stop smoking. J Gen Intern Med (1987) 0.93
Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med (1977) 0.93
Optimal therapeutic range for oral anticoagulants. Chest (1989) 0.92
Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol (1992) 0.91
Physician attitudes toward cost containment. The missing piece of the puzzle. Arch Intern Med (1989) 0.90
Treatment of massive pulmonary embolism: the role of pulmonary embolectomy. Am Heart J (1975) 0.90
Pulmonic stenosis in the adult. Long-term follow-up results. N Engl J Med (1972) 0.90
Dissection of the aorta: pathogenesis, diagnosis, and treatment. Prog Cardiovasc Dis (1981) 0.89
Factors affecting cigarette smoking status in patients with ischemic heart disease. J Chronic Dis (1985) 0.89
A simple technique for detecting small defects of the atrial septum. Am J Cardiol (1971) 0.89
Antithrombotic therapy. Introduction. Chest (1992) 0.88
Response of the right ventricle to exercise in patients with chronic heart disease. Am Heart J (1983) 0.88
Serum estrogen levels in men with acute myocardial infarction. Am J Med (1982) 0.88
Enhancing peer review of scientific manuscripts. Arch Intern Med (1997) 0.88
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest (1995) 0.87
Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1987) 0.87
Pathogenesis of Osler's nodes. Ann Intern Med (1976) 0.87
Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study). Am J Cardiol (1992) 0.87
Outcome after cardiac arrest during acute myocardial infarction. Am J Cardiol (1987) 0.86
Fibrin split products in acute pulmonary embolism. Ann Intern Med (1973) 0.86
Pulmonary hypertension secondary to minor pulmonary embolism. Chest (1978) 0.85
Importance of clinical assessment in selecting patients for pulmonary arteriography. Am J Cardiol (1979) 0.85
Changing concepts in the diagnosis and management of patients with valvular heart disease: a clinician's view. Z Kardiol (1987) 0.85
Venous thromboembolism. Scope of the problem. Chest (1986) 0.84
A new wrinkle to the earlobe crease. Arch Intern Med (1987) 0.84
"Conventional" and "unconventional" medicine: can they be integrated? Arch Intern Med (1998) 0.84
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest (1998) 0.84
Fatal pulmonary hemorrhage after use of the flow-directed balloon-tipped catheter. Ann Intern Med (1979) 0.83
Clinical diagnosis of acute pulmonary embolism. When should a V/Q scan be ordered? Chest (1991) 0.83
Non-Q wave myocardial infarction: recent changes in occurrence and prognosis--a community-wide perspective. Am Heart J (1987) 0.83
Alterations in preload and myocardial mechanics in the dog and in man. Circ Res (1972) 0.83
Coronary spasm, coronary thrombosis and myocardial infarction. Trans Am Clin Climatol Assoc (1982) 0.83
Hemodynamic response to discoid mitral valve replacement. Circulation (1968) 0.82
Occult cancer in patients with acute pulmonary embolism. Ann Intern Med (1982) 0.82